BlackRock Institutional Trust’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$7.65M Buy
2,013,325
+140,100
+7% +$532K ﹤0.01% 2551
2016
Q3
$16.8M Buy
1,873,225
+191,106
+11% +$1.71M ﹤0.01% 2004
2016
Q2
$11.8M Buy
1,682,119
+117,212
+7% +$825K ﹤0.01% 2190
2016
Q1
$13.3M Buy
1,564,907
+114,653
+8% +$975K ﹤0.01% 2082
2015
Q4
$19M Buy
1,450,254
+43,376
+3% +$570K ﹤0.01% 1896
2015
Q3
$5.15M Buy
1,406,878
+204,732
+17% +$749K ﹤0.01% 2700
2015
Q2
$6.92M Buy
1,202,146
+60,328
+5% +$347K ﹤0.01% 2602
2015
Q1
$6.67M Buy
1,141,818
+376,238
+49% +$2.2M ﹤0.01% 2627
2014
Q4
$6M Buy
765,580
+197,495
+35% +$1.55M ﹤0.01% 2643
2014
Q3
$2.79M Sell
568,085
-391,653
-41% -$1.92M ﹤0.01% 2917
2014
Q2
$5.93M Sell
959,738
-209,809
-18% -$1.3M ﹤0.01% 2705
2014
Q1
$6.26M Sell
1,169,547
-1,285,570
-52% -$6.88M ﹤0.01% 2686
2013
Q4
$12.8M Buy
2,455,117
+1,821,803
+288% +$9.53M ﹤0.01% 2253
2013
Q3
$3.5M Buy
633,314
+106,565
+20% +$588K ﹤0.01% 2878
2013
Q2
$1.33M Buy
+526,749
New +$1.33M ﹤0.01% 3241